{"product_id":"b0gnjbylk4","title":"BioLionaire Scientist—Volume 4: CELLULAR EMPIRE: Where Cell Therapy Becomes an Industry","description":"\u003cp\u003eCellular Empire  explores the rise of living drugs — from early T-cell biology to engineered cellular therapies that are redefining oncology and regenerative medicine.\u003c\/p\u003e\n\n\u003cp\u003eThis volume examines how cell therapy evolved from experimental immunology into a manufacturing-driven, venture-backed industry. It connects the biological foundations of T cells and stem cells with the engineering logic behind chimeric antigen receptor (CAR) platforms, induced pluripotent stem cell (iPSC) technologies, and next-generation delivery systems.\u003c\/p\u003e\n\n\u003cp\u003eRather than treating cell therapy as a scientific novelty, this book analyzes the full architecture of platform development: biological mechanism, genetic engineering, manufacturing scalability, regulatory realities, solid tumor challenges, and commercialization pathways. It also addresses what it means to become a builder in this field — moving from bench scientist to founder.\u003c\/p\u003e\n\n\u003cp\u003eDesigned for clinician-scientists, graduate researchers, translational innovators, and biotech entrepreneurs,  Cellular Empire  bridges immunology, bioengineering, and capital formation to show how living drugs become global therapeutic platforms.\u003c\/p\u003e\n\n\u003cp\u003eWho This Book Is For This volume is written for graduate students, postdoctoral fellows, clinician-scientists, translational research teams, cell therapy engineers, and biotechnology founders seeking a rigorous understanding of engineered cell platforms. It is also appropriate for institutional libraries, cancer centers, and biotech incubators training future innovators.\u003c\/p\u003e\n\n\u003cp\u003eTable of Contents Part I - The Science of Living Drugs\u003cbr\u003e\nChapter 1 — The Birth of Living Drugs\u003cbr\u003e\nChapter 2 — T Cells: Nature’s Programmable Soldiers\u003cbr\u003e\nChapter 3 — Engineering CAR T Cells\u003cbr\u003e\nChapter 4 — Manufacturing a Cell Therapy\u003c\/p\u003e\n\n\u003cp\u003ePart II - Next-Gen Therapy\u003cbr\u003e\nChapter 5 — CAR NK and the Rise of Cell Therapies\u003cbr\u003e\nChapter 6 — iPSCs and Stem Cell Engineering\u003cbr\u003e\nChapter 7 — Delivery Platforms for Living Drugs\u003cbr\u003e\nChapter 8 — Cell Therapy in Solid Tumors\u003c\/p\u003e\n\n\u003cp\u003ePart III - The Business \u0026amp; The Builder\u003cbr\u003e\nChapter 9 — The Business of Cell Therapy\u003cbr\u003e\nChapter 10 — Becoming a Cell Therapy Founder\u003c\/p\u003e\n\n\u003cp\u003eAppendices\u003cbr\u003e\nAppendix A — Example SBIR Phase I Grant Proposal\u003cbr\u003e\nAppendix B — Example SBIR Phase II Grant Proposal\u003c\/p\u003e\n\n\u003cp\u003eGlossary\u003cbr\u003e\nIndex\u003cbr\u003e\nCompanies Discussed in this Volume\u003cbr\u003e\nEssential Reading\u003c\/p\u003e","brand":"ANT","offers":[{"title":"Ebook","offer_id":67975248117796,"sku":"YSL61437","price":5.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0805\/2614\/7620\/files\/71yy-10d-6L._SY1500.jpg?v=1793603711","url":"https:\/\/booktavero.com\/products\/b0gnjbylk4","provider":"BookTavero","version":"1.0","type":"link"}